Global Dermal Filler Medical Devices Pipeline Assessment 2019: Products Under Development, Companies & Products, and Recent Developments - ResearchAndMarkets.com

The "Dermal
Filler - Medical Devices Pipeline Assessment, 2019" report has
been added to ResearchAndMarkets.com's offering.

The report provides comprehensive information on the pipeline products
with comparative analysis of the products at various stages of
development. The report reviews major players involved in the pipeline
product development. It also provides information about clinical trials
in progress, which includes trial phase, trial status, trial start and
end dates, and, the number of trials for the key Dermal Filler pipeline
products.

Scope

• Extensive coverage of the Dermal Filler under development
• The report reviews details of major pipeline products which includes,
  product description, licensing and collaboration details and other
  developmental activities
• The report reviews the major players involved in the development of
  Dermal Filler and list all their pipeline projects
• The coverage of pipeline products based on various stages of
  development ranging from Early Development to Approved / Issued stage
• The report provides key clinical trial data of ongoing trials specific
  to pipeline products
• Recent developments in the segment / industry.

Key Topics Covered:

1 Table of Contents

1.1 List of Tables

1.2 List of Figures

2 Introduction

2.1 Dermal Filler Overview

3 Products under Development

3.1 Dermal Filler - Pipeline Products by Stage of Development

3.2 Dermal Filler - Pipeline Products by Territory

3.3 Dermal Filler - Pipeline Products by Regulatory Path

3.4 Dermal Filler - Pipeline Products by Estimated Approval Date

3.5 Dermal Filler - Ongoing Clinical Trials

4 Dermal Filler - Pipeline Products under Development by
Companies

4.1 Dermal Filler Companies - Pipeline Products by Stage of Development

4.2 Dermal Filler - Pipeline Products by Stage of Development

5 Dermal Filler Companies and Product Overview

5.1 Aeon Astron Corporation Company Overview

5.2 Allergan Plc Company Overview

5.3 Almirall Ltd Company Overview

5.4 Bioxis Pharmaceuticals Company Overview

5.5 BMG Pharma srl Company Overview

5.6 Bmi Korea Co Ltd Company Overview

5.7 Celltrix AB Company Overview

5.8 CollPlant Holdings Ltd Company Overview

5.9 EternoGen Aesthetics LLC Company Overview

5.10 Genzyme Corp Company Overview

5.11 Innovia LLC Company Overview

5.12 Juvenis Ltd Company Overview

5.13 Khorionyx SA Company Overview

5.14 Medy-Tox Inc Company Overview

5.15 Mesoestetic Pharma Group SL Company Overview

5.16 Moma Therapeutics, Inc. Company Overview

5.17 N8 Medical Inc Company Overview

5.18 Oligo Medic Inc Company Overview

5.19 PB&B SA Company Overview

5.20 PetVivo Holdings Inc Company Overview

5.21 Regenscientific Company Overview

5.22 Samyang Biopharmaceuticals Corp Company Overview

5.23 Sebana Medical Ltd Company Overview

5.24 Sekisui Medical Co Ltd Company Overview

5.25 Shanghai Haohai Biological Technology Co Ltd Company Overview

5.26 Shin Poong PharmCo Ltd Company Overview

5.27 Sinclair Pharma PLC Company Overview

5.28 Sofregen Medical Inc Company Overview

5.29 TEI Biosciences Inc Company Overview

5.30 University of California Santa Barbara Company Overview

6 Dermal Filler- Recent Developments

6.1 Jul 19, 2018: Suneva Medical promotes Patricia Altavilla to chief
operating officer

6.2 Jul 05, 2018: Sinclair Pharma: Trading Update for the 6 months to 30
June 2018

6.3 Jun 04, 2018: SWAG Penis Enhancement Procedure Developed by Top
Plastic Surgeon Achieving Optimal Results

6.4 May 21, 2018: Nestle Skin Health Announces the FDA Approval of
Restylane Lyft for Hands, the First and Only Hyaluronic Acid (HA) Dermal
Filler for Use in the Back of Hands

6.5 May 15, 2018: BTG: Final Results For year ended 31 March 2018

6.6 May 09, 2018: FibroGen Reports First Quarter 2018 Financial Results

6.7 May 08, 2018: Smith & Nephew: Change of Directorate

6.8 May 08, 2018: CollPlant Files U.S. Patent Application for Next
Generation Dermal Filler

6.9 May 03, 2018: Smith & Nephew First Quarter 2018 Trading Report

6.10 May 02, 2018: Anika Reports First Quarter 2018 Financial Results

6.11 Apr 30, 2018: Sinclair Pharma: Preliminary results for 12 months
ended 31 December 2017

6.12 Apr 30, 2018: Sinclair secures 23 million debt facility

6.13 Apr 09, 2018: Merz Aesthetics Launches New Belotero Lips Dermal
Filler Products

6.14 Apr 04, 2018: Namal Nawana appointed Chief Executive Officer of
Smith & Nephew

6.15 Mar 20, 2018: Governor Abbott Announces Smith & Nephew Adding New
Jobs In Fort Worth

6.16 Mar 05, 2018: Anika Therapeutics Names Joseph Darling As CEO And
Director

6.17 Mar 01, 2018: Smith & Nephew: Change in Directorate

6.18 Feb 27, 2018: FibroGen Announces Fourth Quarter and Full Year 2017
Financial Results

6.19 Feb 21, 2018: Anika Announces Fourth Quarter and Full Year 2017
Financial Results

6.20 Feb 16, 2018: Merz North America to Highlight Treatments at
American Academy of Dermatology Annual Meeting

6.21 Feb 08, 2018: Smith & Nephew Fourth Quarter Trading and Full Year
2017 Results

6.22 Jan 31, 2018: Smith & Nephew Appoints Roland Diggelmann As
Non-Executive Director

6.23 Jan 31, 2018: Appointment of Roland Diggelmann as Non-Executive
Director

6.24 Jan 16, 2018: Galderma Introduces Restylane Skinboosters

6.25 Jan 16, 2018: Sinclair Pharma: Ellanse Approved for Brazil

7 Appendix

For more information about this report visit https://www.researchandmarkets.com/research/gzqq66/global_dermal?w=4

View source version on businesswire.com: https://www.businesswire.com/news/home/20190225005535/en/